secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lucid Diagnostics Inc. (LUCD)
CIK:        0001799011
Form:       8-K
Filed at:   2026-06-24T21:00:31+00:00
Accession:  0001493152-26-029943
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lucid Diagnostics shareholders approve increase in authorized common shares from 300M to 400M
--------------------------------------------------------------------------------

- Amendment approved: 152,941,468 for, 12,113,250 against, 382,419 abstain; effective June 24, 2026.
- All three Class B director nominees re-elected: James L. Cox, John R. Palumbo, Ronald M. Sparks.
- Ratification of CBIZ CPAs P.C. as independent auditor for FY 2025 approved (161.8M votes for).
- Approximately 84.7% of outstanding shares represented at the annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799011/000149315226029943/0001493152-26-029943-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799011/000149315226029943/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-029943

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer